Literature DB >> 19559496

Limitations of dual time point PET in the assessment of lung nodules with low FDG avidity.

Francis J Cloran1, Kevin P Banks, Won S Song, Young Kim, Yong C Bradley.   

Abstract

FDG PET has long shown efficacy in the evaluation of indeterminate pulmonary nodules. More recently, the use of dual time point imaging has been looked at as a means for improving sensitivity and accuracy. While initial reports were very promising, more recent results looking specifically at pulmonary lesions with low levels of FDG avidity demonstrated limitations. These lesions (initial maximum standard uptake value of less than 2.5) are of particular interest due to the fact that well-differentiated adenocarcinomas, broncheoaveolar carcinoma and carcinoid may have low FDG avidity on standard PET imaging, leading to false-negative exams. Our study retrospectively reviewed the accuracy of dual time point (DTP) FDG PET imaging to determine if it aided in the identification of malignant pulmonary nodules when initial time point imaging showed a maximum SUV of less than 2.5. 113 patients had undergone a total of 130 DTP PET/CT with 152 lesions assessed. 67 lesions were subsequently definitively diagnosed as benign or malignant based upon biopsy or imaging follow-up. Utilizing a maximum SUV increase of 10%, which optimizes our sensitivity and specificity; our results demonstrate a sensitivity of 63% and a specificity of 59%, similar to other investigators evaluating lesions with low FDG avidity. Increasing or decreasing this threshold did not improve our results, nor did the addition of lesions with maximum SUV's of 2.5 or greater on initial imaging. Specifically in nodules with low FDG avidity (max SUV<2.5), the sensitivity was 61%, specificity 58%, and accuracy was 60%. Our findings suggest that DTP FDG PET may not be of benefit in the assessment of pulmonary nodules with maximum SUV of less than 2.5 on initial imaging. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19559496     DOI: 10.1016/j.lungcan.2009.05.013

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  16 in total

1.  Clinical significance of primary lesion FDG uptake for choice between oesophagectomy and endoscopic submucosal dissection for resectable oesophageal squamous cell carcinomas.

Authors:  Masatoyo Nakajo; Masayuki Nakajo; Atsushi Tani; Yoriko Kajiya; Shunji Shimaoka; Akio Matsuda; Tatsuyuki Nioh; Tohru Nihara; Toyokuni Suenaga; Sadao Tanaka; Hiroshi Shirahama; Michiyo Higashi; Chihaya Koriyama
Journal:  Eur Radiol       Date:  2011-07-13       Impact factor: 5.315

2.  Patlak image estimation from dual time-point list-mode PET data.

Authors:  Wentao Zhu; Quanzheng Li; Bing Bai; Peter S Conti; Richard M Leahy
Journal:  IEEE Trans Med Imaging       Date:  2014-04       Impact factor: 10.048

3.  A case of early stage lung cancer detected by repeated cancer screening with positron emission tomography.

Authors:  Ikuko Sakata; Yuichi Ozeki; Katsumi Tamura; Jiro Ishida; Shinsuke Aida; Yoshiyuki Abe
Journal:  Oncol Lett       Date:  2011-11-22       Impact factor: 2.967

4.  The clinical value of texture analysis of dual-time-point 18F-FDG-PET/CT imaging to differentiate between 18F-FDG-avid benign and malignant pulmonary lesions.

Authors:  Masatoyo Nakajo; Megumi Jinguji; Masaya Aoki; Atsushi Tani; Masami Sato; Takashi Yoshiura
Journal:  Eur Radiol       Date:  2019-11-14       Impact factor: 5.315

Review 5.  International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Authors:  William D Travis; Elisabeth Brambilla; Masayuki Noguchi; Andrew G Nicholson; Kim R Geisinger; Yasushi Yatabe; David G Beer; Charles A Powell; Gregory J Riely; Paul E Van Schil; Kavita Garg; John H M Austin; Hisao Asamura; Valerie W Rusch; Fred R Hirsch; Giorgio Scagliotti; Tetsuya Mitsudomi; Rudolf M Huber; Yuichi Ishikawa; James Jett; Montserrat Sanchez-Cespedes; Jean-Paul Sculier; Takashi Takahashi; Masahiro Tsuboi; Johan Vansteenkiste; Ignacio Wistuba; Pan-Chyr Yang; Denise Aberle; Christian Brambilla; Douglas Flieder; Wilbur Franklin; Adi Gazdar; Michael Gould; Philip Hasleton; Douglas Henderson; Bruce Johnson; David Johnson; Keith Kerr; Keiko Kuriyama; Jin Soo Lee; Vincent A Miller; Iver Petersen; Victor Roggli; Rafael Rosell; Nagahiro Saijo; Erik Thunnissen; Ming Tsao; David Yankelewitz
Journal:  J Thorac Oncol       Date:  2011-02       Impact factor: 15.609

6.  Dynamic changes of FDG uptake and clearance in normal tissues.

Authors:  Gang Cheng; Abass Alavi; Esther Lim; Thomas J Werner; Catherine V Del Bello; Scott R Akers
Journal:  Mol Imaging Biol       Date:  2013-06       Impact factor: 3.488

Review 7.  When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET?

Authors:  Gang Cheng; Drew A Torigian; Hongming Zhuang; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-30       Impact factor: 9.236

8.  Current state of oncologic 18F-FDG PET/CT in Japan: A nationwide survey.

Authors:  Hajime Ichikawa; Toyohiro Kato; Kenta Miwa; Takayuki Shibutani; Koichi Okuda; Akio Nagaki; Hiroyuki Tsushima; Masahisa Onoguchi
Journal:  Asia Ocean J Nucl Med Biol       Date:  2021

9.  FDG PET/CT evaluation of pathologically proven pulmonary lesions in an area of high endemic granulomatous disease.

Authors:  Ronnie Sebro; Carina Mari Aparici; Miguel Hernandez-Pampaloni
Journal:  Ann Nucl Med       Date:  2013-02-12       Impact factor: 2.668

10.  FDG-PET/CT finding of benign metastasizing leiomyoma of the lung.

Authors:  Masatoyo Nakajo; Hirofumi Nakayama; Masayuki Sato; Yoshihiko Fukukura; Masayuki Nakajo; Yoriko Kajiya; Masakazu Yanagi; Kazuhiro Tabata; Michiyo Higashi
Journal:  Acta Radiol Short Rep       Date:  2012-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.